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ABASTRACT 
 
The minichromosome maintenance (MCM) complex is essential for DNA replication 
in eukarya and archaea and is thought to function as the replicative helicase. While in 
eukarya the MCM is a complex of six highly conserved but nonidentical polypeptides 
(Mcm2-7), most archaeal species contain 6 identical polypeptides. In a N-ethyl-N-
nitrosourea (ENU) mutagenesis screen for mice showing chromosome instability, a 
mutant mouse was identified which harbored a mutation in MCM4 protein referred to 
as Chaos3 (chromosome aberrations occurring spontaneously 3). MCM4Chaos3 mice 
harbor a single amino acid substitution (F345I) in which a conserved phenylalanine 
residue in MCM4 protein is replaced by isoleucine. Female mice homozygous for the 
mutation are susceptible to mammary adenocarcinomas. Similar mutations in the 
budding yeast homologue of MCM4 resulted in a strong minichromosome loss 
phenotype. Using the single MCM homologue from the archaeon 
Methanothermobacter thermautotrophicus (mtMCM), we show that the equivalent 
mutation (F172I) affects the stability and activity of the helicase. The implications of 
these observations for the eukaryotic MCM functions are discussed. 
 Besides the biochemical characterization, I have carried out structural studies of 
mutant proteins using Small Angle X-ray Scattering (SAXS) to illustrate the structural 
effect of F172I mutation. Some preliminary results are presented to show that F172I 
mutation does affect the structural integrity of N-terminal mtMCM protein. 
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PREFACE 
 
 To maintain the integrity of the genome, cell needs to precisely regulate a 
series of important molecular events, such as DNA replication, chromosomal 
segregation and surveillance and repair of damaged DNA. One of the key players in 
replication is the replicative helicase. The minichromosome maintenance (MCM) 
complex also known as the replicative helicase is involved in DNA replication 
initiation and elongation in eukaryotes and archaea, the MCM proteins were first 
identified as protein required for mini-chromosome maintenance in Saccharomyces 
cerevisiae by Bik-Kwoon Tye’s laboratory in the early 1980s. MCM is also the target 
of various checkpoint pathways, such as the S-phase entry and S-phase arrest 
checkpoints. Both the loading and activation of MCM helicase are strictly regulated 
and are coupled to cell growth cycles. Defects in MCM function has been linked to 
genomic instability and a variety of carcinomas (Chapter I). 
During a N-ethyl-N-nitrosourea (ENU) mutagenesis screen for mice showing 
chromosome instability, a mutant mouse was identified which harbored a mutation in 
MCM4 protein referred to as Chaos3 (chromosome aberrations occurring 
spontaneously 3).  The mutation in Mcm4Chaos3 is a substitution of a conserved Phe 
residue by Ile.  It was found that females that are homozygous for the mutation are 
susceptible to mammary adenocarcinomas with a mean latency of 12 months, 
whereas homozygous males did not show any significant increase in tumor 
incidence.  It was also found that the mutation affects the stability of the MCM4. 
Similar mutations in the budding yeast homologue of MCM4 resulted in a strong 
minichromosome loss phenotype. The yeast mutant bearing the equivalent allele 
recapitulates many of the mouse mutant phenotype including chromosome 
instability, G2/M delay and a predisposition of the mutant to acquire improved 
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proliferation rate. But the biochemical mechanism of how this mutation affects the 
emzyme is not clear.  
The Phe residue, mutated in MCM4Chaos3, is not only conserved in the 
eukaryotic MCM4 proteins but also in the archaeal MCM protein.  Thus, the MCM 
homologue from the archaeon Methanothermobacter thermautotrophicus (mtMCM) 
was used to study the effect of MCM4Chao3 mutation on MCM functions. All archaeal 
MCM proteins studied to date are from organisms with a single MCM gene in their 
genome thus is considered as a simple model for understanding the MCM function 
and structure relationship. Biochemical characterization of both full-length and N-
terminal mtMCM proteins harboring the equivalent mutation of MCM4Chao3 have 
been performed to reveal the effect of mutation F172I on the enzyme (Chapter II). 
Structural effects of equivalent MCM4Chao3 mutation (F172I) on N-terminal 
mtMCM have also been investigated. Until recently there is no high resolution 
structure of the full length mtMCM protein available. Although Xraycrystallographic 
structures of the N-terminal portion of mtMCM has been solved, my efforts to 
crystallize N-terminal F172I mutant protein failed. Thus we used structure 
simulation and Small Angle X-ray Scattering (SAXS) to examine the structural 
effects of F172I mutation on N-terminal mtMCM protein.  Preliminary results are 
presented and discussed as a supplementary to the biochemical characterization in 
Chapter III. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 DNA replication 
 To maintain the integrity of a genome, the cell needs to precisely regulate a 
series of important genetic events, such as DNA replication, chromosomal division 
and recognition and reparation of damaged DNA. Defects in any of these processes 
may cause genomic instability, potentially leading to cancer or death (1).  
 DNA replication is one of the most essential events in the cell that involves 
dozens of proteins and enzymes to ensure that genetic information is duplicated in an 
accurate and timely manner. DNA replication is functionally and often structurally 
conserved in all life forms and is divided into three main stages: initiation, elongation 
and termination (2). During the S phase of the cell cycle, DNA replication is initiated 
at particular points within the genome, known as replication "origins”, which contain 
DNA sequences recognized by replication initiator proteins. Initiator proteins recruit 
other origin binding proteins (OBP) to separate the DNA strands at the origin, forming 
a bubble. The replicative helicase is recruited to unwind the double stranded (ds) DNA 
in a bidirectional manner and the ssDNA binding proteins (SSB) bind to ssDNA to 
prevent it from reannealing or breaking down. Once strands are separated, RNA 
primers are synthesized on the template strands and DNA polymerase extends these to 
create newly synthesized DNA. As DNA synthesis continues, the parental DNA 
strands continue to unwind on each side of the bubble, forming replication forks. 
Because bacteria have a single origin of replication in their circular chromosome, the 
termination of replication occurs when the two progressing replication forks meet each 
other in the circular chromosome. In contrast, eukaryotes initiate DNA replication at 
multiple origins in their linear chromosome, so replication forks meet and terminate at 
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many points in the chromosome, but it is unclear that how the termination of 
replication ends (3,4).  
 One of the key events in the initiation of replication is the assembly of helicase 
at the origin. The minichromosome maintenance (MCM) protein is known as the 
replicative helicase in eukaryotes and archaea, which is an essential factor in DNA 
replication initiation and elongation (5). 
 
1.2 Helicases 
 Helicases, a group of enzymes that catalyze the unwinding of duplex DNA, are 
required for accessing single strand DNA (ssDNA) template and separating template 
DNA strands on replication forks. They use the energy generated in enzymatic 
nucleoside triphosphate (NTP) hydrolysis to translocate along one strand of the DNA 
duplex, thus displacing the complementary strand from the duplex (6). DNA helicases 
work in association with other proteins as part of a complex machine in DNA 
replication, repair, and recombination. However, in vitro, most helicases by 
themselves are able to catalyze the strand separation or unwinding process with the 
presence of suitable DNA or RNA substrate (7). Helicases can unwind substrate in 
different unwinding directions: 5′ → 3′ (as dnaB helicase) or 3′ → 5′ (as MCM 
helicase). Though most of helicases unwind either DNA or RNA, some can unwind 
both (7). 
 The integrity of genetic information depends on efficient helicase reactions, 
therefore, it is not surprising that defects in helicases may lead to disorders in the cell. 
Most of these disorders are characterized by genetic instability caused by defects in 
DNA repair, recombination, or replication processes (7). 
 
1.3 MCM helicase 
  3 
The minichromosome maintenance (MCM) protein was first identified as protein 
required for mini-chromosome maintenance in Saccharomyces cerevisiae by Bik-
Kwoon Tye’s laboratory in the early 1980s. MCM proteins are known as the 
replicative helicase involved in DNA replication initiation and elongation in 
eukaryotes and archaea. They are also implicated in many other chromosome 
transactions including transcription, chromatin remodeling, and genome stability (1). 
The MCM proteins are distinct members of AAA ATPase family, which has many 
cellular functions. AAA ATPases generally form large ATP-dependent complexes, 
often heterohexamers. The MCMs contain a characteristic version of the ATPase 
domain, the “MCM box”, which spans 200 residues. The MCM box includes two 
ATPase consensus motifs, Walker A and Walker B. The Walker A motif contains the 
P-loop of the active site. The Walker B motif contains the sequence IDEFDKM, which 
is conserved in all MCM proteins and defines the MCM family, and is thought to 
contribute to ATP hydrolysis. Another short motif, SRFD, called the “arginine finger”, 
usually occurs about 70 residues after the Walker B element. All MCMs contain these 
sequences. All eukaryotic MCMs have zinc-binding motifs, and studies show that the 
zinc-binding motifs in several MCMs are required for viability, and may also 
contribute to complex assembly and ATPase activity (1,5). 
 
1.3.1 Eukaryotic MCMs  
 In eukarya, the MCM complex consists of six essential proteins (Mcm2−7) that 
each contains a conserved C-terminal helicase domain and divergent N-terminal 
sequence. Mcm2-7 proteins form a heterohexameric complex, which is a key 
component of the pre-replication complex (pre-RC) that assembles on replication 
origins before S phase. The assembly of the pre-RC, involving several conserved 
initiation proteins like the ORC (origin recognition complex), Cdc6, Cdt1, and the 
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Mcm2-7 complex, initiates DNA replication which is strictly controlled so that 
chromosomal DNA is duplicated only once per cell cycle (5,8).   
 In vivo experiments indicate that all six proteins are required for the initiation 
and elongation steps of replication (9). In addition to forming a heterohexamer, in vivo 
and in vitro studies have revealed the existence of several MCM subcomplexes (10). 
Biochemical studies have shown that a dimeric complex of the Mcm4,6,7 heterotrimer 
possesses weak 3’→5’ DNA helicase activity, can translocate on single and double 
stranded DNA, can bind DNA and RNA, and has the ability to unwind DNA-RNA 
duplexes while translocating on the DNA strand. The interaction of Mcm4,6,7 
complex with either MCM2 or the MCM3,5 dimeric complex inhibits the helicase 
activity, suggesting regulatory function of these Mcm proteins (11,12). A recent study 
detects helicase activity of the Mcm2-7 complex in vitro, although it is strongly anion 
dependent.  It was also suggested that that Mcm2,5 plays a role in regulation of 
Mcm4,6,7, possibly as a gate of the ring opening in order to be loaded onto the DNA 
in the Mcm2-7 complex (13).  
The archaeal MCM and all eukaryotic MCMs share a well conserved C-
terminal domain, which contains the helicase domain, similar to other hexameric 
helicases functioning in origin melting and fork DNA unwinding. The N-terminal 
domain, less conserved among all MCMs, binds DNA and is required for 
multimerization (5).  
 
1.3.2 Archaeal MCMs 
 There are three domains of life, bacteria, eukarya and archaea (14). Although 
archaea share similarity to bacteria in terms of cell structure and metabolism due to 
their prokaryotic nature, some archaeal proteins involved in replication, transcription, 
and translation share more similarities with those from eukaryotes (15). 
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 MCM homologs have also been identified in archaea, and at least one MCM 
homologue has been identified in all archaea sequenced to date (16). Based on 
structural and biochemical features it is thought that the archaeal MCM proteins 
function as the archaeal replicative helicase. Several archaeal MCM helicases have 
been studied, and their biochemical properties have been described. The helicases 
from most archaea form hexamers in solution, have an ATP-dependent 3’→5’ helicase 
activity, bind and translocate along ssDNA (single-stranded DNA) and dsDNA 
(double-stranded DNA), can unwind DNA–RNA hybrids while moving along the 
DNA strand, and can displace proteins from DNA (17).  
 Currently, the following archaeal MCM X-ray structures have been determined: 
the N-terminal structures for mthMCM (18) and ssoMCM (19), a near full-length 
ssoMCM structure (20), and an MCM homolog from another archaeon, M. kandleri 
(mkaMCM2) (21) (reviewed in Ref. 17). These archaeal MCM structures have 
provided valuable information for understanding the enzymatic mechanism of MCM 
helicase. 
 
1.4 Methanobacterium thermoautotrophicum MCM helicase 
Methanothermobacter thermautotrophicus is a methanogenic archaeabacteria 
which grows and gains energy through the conversion of hydrogen and carbon dioxide 
to methane with an optimal growth temperature between 62 ~ 65ºC (22). The M. 
thermautotrophicus genome contains one replication origin, one eukaryotic MCM 
helicase homologue, and two homologues of the putative helicase loader and OBP, 
Cdc6 (23). The M. thermoautotrophicus MCM homolog (MtMCM, ~76 kDa), similar 
to the eukaryotic MCM4 (1,5), has been shown to have helicase activity in vitro (16). 
M. thermautotrophicum MCM is 34% identical and 51% similar in sequence to the 
MCM2-7 protein family with the strongest homology concentrated in three conserved 
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motifs, two of which are the Walker A and B nucleotide binding sequence (24). Thus 
this simpler system is a good model for eukaryotic MCM complex and to establish its 
role in replication. 
 
1.4.1 Biochemical properties 
 M. thermoautotrophicus MCM helicase has similar enzymatic activities as 
eukaryotic MCM complex. It binds DNA, has DNA-stimulated ATPase activity, and 
unwinds duplex DNA in the 3’→5’ direction in an ATP-dependent reaction (17). All 
these features make mtMCM protein a simpler experimental model for studying 
helicase function in DNA replication in both archaeal and eukaryotic systems.  
 
1.4.1.1 Helicase activity 
 All archaeal MCM proteins unwind substrates in the direction of 3’→5’. 
Substrates with 3’ overhang available are required for helicase assay and better 
activity is detected when a 5’ overhang is also present [25-28].  MtMCM protein was 
also shown to prefer the forked like substrate (both 3’ and 5’- overhang dsDNA) over 
a flat substrate (only 3’-overhang dsDNA) (27). As it translocates along the DNA, the 
MtMCM helicase can displace proteins such as transcription factor and histones bound 
on DNA from the substrate (29). MtMCM can also displace DNA-RNA duplex 
substrate while translocating along the DNA, suggesting multiple roles besides that of 
a helicase in DNA replication (29). 
 
1.4.1.2 ATPase activity 
 Helicases are motor proteins that couple the hydrolysis of nucleoside 
triphosphate (NTPase) to nucleic acid unwinding (30). All archaeal MCM helicases 
have ATPase activity, some of which can be stimulated in the presence of DNA. In 
  7 
MtMCM protein, ATPase activity is strongly dependent on the presence of either ss or 
dsDNA (31) and ATP binding enhances DNA binding by the helicase (25). 
 
 
1.4.1.3 DNA binding 
 Archaeal MCM helicases must interact with DNA to have helicase activity.  
Binding constants (Kd) of archaeal MCM to different DNA substrates have been 
reported to vary from 10 to 300 nM (32). ATP stimulates the DNA binding ability of 
MtMCM protein, although the stimulatory effect of ATP on DNA binding can only be 
detected when the reaction is incubated at 50-60ºC. No change in DNA binding could 
be detected in the presence of ATP when the DNA binding reactions were incubated at 
22ºC (26,32). 
 
1.4.2 Structural studies of M. thermautotrophicus MCM helicase 
 The M. thermoautotrophicus MCM can be divided into three parts. An N-
terminal region, a middle region, which contains the helicase catalytic domains, and a 
C-terminal region which was suggested to fold into a helix-turn-helix motif (20,21). 
High-resolution structural information is not yet available for the full-length MtMCM 
protein, but an X-ray crystallographic structure of the N-terminal portion of MtMCM 
has been reported. EM studies have shed light on the overall MtMCM structure as well 
as its unique properties. 
 
1.4.2.1 X-ray crystallographic structures 
 A 3.1 Å crystal structure of the N-terminal domain (N-mtMCM) reveals a 
unique double-hexamer architecture: a dumbbell, slim in the center with large bulges 
at both ends (18). The dodecamer has an unusually long (118 Å) and highly positively 
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charged central channel that binds dsDNA. The wall of the channel is made of β-
strands, while the bulges around the outside are α-helices. 
  
 
Figure 1.1 Crystal structure of N-terminal mtMCM double hexamer. A. Top view of double-
hexamer structure. B. Side view of double-hexamer structure. C. A monomer structure of N-mtMCM. 
 
 Each unit has a three-domain structure (16). Domain A, at the N terminus, is 
mostly α-helical. Domain B has three β-strands and contains a zinc-finger motif 
shown to be needed for DNA binding. Domain C contains five β-strands that form an 
oligonucleotide/oligosaccharide binding (OB) fold.  
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Figure 1.2 Domain structure of N-terminal mtMCM monomer. Domain organization and the main 
structural motifs are shown. The N-terminal part is divided into three domains, A (Blue), B (Green) and 
C (Magentas). NCL, N-terminal communication loop; C-term, C-terminal end; N-term, N-terminal end. 
 
This domain connects the N-terminal portion of the enzyme to the C-terminal catalytic 
region.  Domain C contains a zinc-finger motif shown to be essential for ssDNA and 
dsDNA binding and a conserved loop, N-terminal communication loop (NCL), which 
plays a role in communication between the N-terminal DNA binding region and the 
catalytic part. Domain C was also shown to play a major role in MCM 
multimerization. 
 
1.4.2.2 Electron microscopy (EM) structures  
 Low-resolution electron micrograph reconstruction studies have been performed 
on the full-length MCM protein from the archaeon M. thermautotrophicus.  
 
Figure 1.3 Average images of the different populations found in one mtMCM preparation under 
EM. This figure is cited from “Ref. 33 Figure 2”. These images were obtain under solution containing 
250mM NaCl, 2mM AMP-PNP, and 5mM NTP after 1 hour incubation at 37 °C. A) 6-fold ring view; 
B) 7-fold ring view; C) open ring view; D) 2-fold titled ring view; E) side view. 
 
 
 The first image that MtMCM obtained by EM revealed a cylindrical structure 
  10 
showing that it exists as a double hexamer (26). MtMCM was also found to assemble 
into a heptameric ring by EM, together with many larger aggregates in the image, 
consistent with side views of ‘stacks’ of rings (24). A recent EM study of full-length 
MtMCM revealed several oligomeric forms (33). Two different types of morphology 
were found in series of solutions. One is ring-shaped objects, top views of either a 
single or a double ring. The other is rectangle-shaped particles with four density 
bands, consistent with side views of a double ring. Analysis of ring views revealed a 
mixture of 6-fold and 7-fold symmetry forms. Open ring forms were also found in 
some conditions. In the double ring the 6-fold arrangement was preferred, forming the 
double hexamer structure.  
 These studies suggest that full-length MtMCM protein can adopt multiple forms 
in solution: hexamers, heptamers, dodecamers, filaments and open rings. These 
structures may be dependent on the treatment of the samples prepared for the EM 
studies.  Nonetheless, the flexibility to form various oligomers may be a mechanism of 
regulation.  
 
1.4.2.3 Comparison of major approaches for protein structure analysis 
A) X-ray Crystallography 
  Around 90% of the protein structures available in the Protein Data 
Bank were determined by X-ray crystallography. This technique measures 
the 3D density distribution of electrons in the protein (in the crystallized 
state) and thereby infers the 3D coordinates of all the atoms to be 
determined. Comparing to other methods, X-ray crystallography can 
produce the highest resolution data (up to 1 Å) revealing fine details of 
atomic structures. It requires high quality protein crystals to perform the 
experiment but not all proteins can be crystallized, particularly in the case 
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of large protein complexes. As the structure information is obtained under 
crystallized state, flexible portions of protein molecules are sometimes not 
seen with X-ray crystallography and the protein structure may be 
influenced by crystal packing forces, which arguably can lead to 
undesirable conformational changes (34). 
 
B) Nuclear Magnetic Resonance (NMR) 
  Roughly 9% of the known protein structures have been obtained by 
the Nuclear Magnetic Resonance (NMR) technique, which can also be used 
to determine secondary structure. It has relatively high resolution (2-3 Å) 
and it examines proteins in solution, which is close to physiological 
environment than crystals. But NMR has a strict limitation on protein size, 
hardly applicable for protein whose molecular weight exceeding 30 kDa 
(34). 
 
C) Cryo-electron microscopy (Cryo-EM) 
  Cryo-electron microscopy (Cryo-EM) has recently become a method 
of determining 3D protein structure to a moderate resolution (~10Å). This 
technique is a valuable resource for studying very large protein complexes 
such as virus coat proteins and amyloid fibers. Compared to the above two 
methods, Cryo-EM uses low amount of protein and gives direct 
visualization of particle shape and symmetry. Cryo-EM has lower 
resolution than X-ray crystallography or NMR and it also has size 
limitation, hardly applicable for protein molecules whose molecular 
weights are less than 200 kDa (34). 
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D) Small-angle X-rays scattering (SAXS) 
  Small-angle X-rays scattering (SAXS) is another fundamental tool in 
the study of biological macromolecules. The major advantage of the 
method lies in its ability to provide structural information about partially or 
completely disordered systems. SAXS allows one to study native particles 
in nearly physiological solutions and to analyze structural changes in 
response to variations in external conditions thus yielding valuable 
information on the relationship between these structural changes and the 
operation of these systems. Despite its low resolution limitation (10-20Å), 
the method is a general tool for studying the structure, kinetics and 
interactions of biological macromolecules in solution. SAXS is applicable 
to macromolecules with very different sizes (few kDa to hundreds MDa). 
Moreover, for complexes with molecular mass of a few hundred kDa, too 
large for NMR and too small for cryo-EM, SAS remains effectively the 
only method to obtain their shape in solution. The biggest limitation of this 
method is that it requires additional information to resolve ambiguity in 
model building, so it usually needs to work together with other major 
methods (34). 
 
E) Other methods 
   Static and dynamic light scattering and ultracentrifugation methods 
are also used to gain 3D information of biological macromolecules. These 
methods are simple to setup, non-destructive to samples and requires low 
amount of proteins. But they only yield overall parameters of the protein 
molecules in solution, and thus are used to provide supportive information 
for other high-resolution methods (34). 
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CHAPTER 2 
BIOCHEMICAL CHARACTERIZATION OF MCM4CHAOS3 MUTATION USING 
AN ARCHAEAL MCM AS A MODEL 
 
2.1 Abstract 
 The minichromosome maintenance (MCM) complex is essential for DNA 
replication in eukarya and archaea and is thought to function as the replicative 
helicase. While in eukarya the MCM is a complex of six polypeptides (Mcm2-
7), most archaeal species contain a single homologue.  MCM4Chaos3 mice harbor 
a single amino acid substitution in which a conserved phenylalanine residue in 
MCM4 protein is replaced by isoleucine. Female mice homozygous for the 
mutation are susceptible to mammary adenocarcinomas. Using the single MCM 
homologue from the archaeon Methanothermobacter thermautotrophicus, we 
show that the equivalent mutation (F172I) affects the stability and activity of the 
helicase.  The implications of these observations for the eukaryotic MCM 
functions are discussed. 
 
2.2 Introduction 
 The integrity of genomic information depends on the precise regulation of 
DNA replication, a process which involves a complicated network of proteins. 
The helicase is one of the enzymes that play an essential role in the process. The 
mini-chromosome maintenance (MCM) is thought to function as the replicative 
helicase in eukarya. MCM is a family of six conserved proteins, Mcm2-7, that 
forms a heterohexameric complex.  It was shown that all six proteins are 
essential for the initiation and elongation phases of DNA replication (reviewed 
in: (1-4)).  
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 In a N-ethyl-N-nitrosourea (ENU) mutagenesis screen for mice showing 
chromosome instability, a mutant mouse was identified which harbored a 
mutation in MCM4 protein referred to as Chaos3 (chromosome aberrations 
occurring spontaneously 3) (5,6). The mutation in Mcm4Chaos3 is a substitution of 
a conserved Phe residue by Ile (5).  It was found that females that are 
homozygous for the mutation are susceptible to mammary adenocarcinomas 
with a mean latency of 12 months, whereas homozygous males did not show any 
significant increase in tumor incidence (5,6).  It was also found that the mutation 
affects the stability of the MCM4 in vivo as reduced amount of proteins was 
observed in cell harboring the MCM4Chaos3 mutation (5).  Similar mutations in 
the budding yeast homologue of MCM4 resulted in a strong minichromosome 
loss phenotype (5). A yeast mutant bearing the equivalent allele was recently 
characterized. The yeast mutant recapitulates many of the mouse mutant 
phenotype including chromosome instability, G2/M delay and a predisposition 
of the mutant to acquire improved proliferation rate (8). 
 MCM has also been suggested to function as the replicative helicase in 
archaea (reviewed in: (9-12)). All archaeal MCM proteins studied to date are 
from organisms with a single gene encoding for MCM in their genome.  
Biochemical studies with several archaeal MCM proteins revealed biochemical 
properties which are similar to those of the eukaryotic MCM complex.  They 
include ATP-dependent 3′→5′ helicase activity, binding and translocating along 
single-stranded (ss) and double-stranded (ds) DNA and unwinding of DNA–
RNA hybrids while moving along the DNA strand and to displace proteins from 
DNA (reviewed in: (10,12)). 
 The archaeal MCM helicases can be divided into three parts; N-terminal 
region needed for protein multimerization, a middle part which contains the 
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helicase catalytic domains, and a C-terminal region which was suggested to fold 
into a helix-turn-helix motif (13,14).  High-resolution three-dimensional 
structures of the N-terminal portion of the MCM proteins from 
Methanothermobacter thermautotrophicus (15) and Sulfolobus solfataricus (16) 
revealed a three domain structures (Fig. 2.1A).  Domain A, at the N terminus, is 
mostly a-helical. Domain B has three β-strands and contains a zinc-finger motif 
shown to be needed for DNA binding (17-19). Domain C contains five b-strands 
that form an oligonucleotide/oligosaccharide binding (OB) fold. This domain 
connects the N-terminal portion of the enzyme to the C-terminal catalytic region.  
Domain C contains a β-finger motif shown to be essential for ssDNA and 
dsDNA binding (15,18) and a conserved loop, the N-terminal communication 
loop (NCL), which plays a role in communication between the N-terminal DNA 
binding region and the catalytic portion (20,21).  Domain C was also shown to 
play a major role in MCM multimerization (22).   
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Figure 2.1 The location of the Phe 172 residue in the MCM structure. A. Phenylalanine 172 of 
mtMCM is conserved in the eukaryotic MCM4 proteins. Sequence alignment of the region of 
mtMCM containing F172 with MCM4 proteins from Mus musculus, MmMCM4; Homo sapiens, 
HsMCM4; Xenopus laevis, XlMCM4 and Saccharomyces cerevisiae, ScMCM4.  Residues that are 
conserved in all sequences are shown in green and Phe 172 of mtMCM is boxed in red. B. The 
structure of the mtMCM N-terminal region. Domain A is shown in blue, domain B in green and 
domain C in magenta.  Phe172 is labeled in yellow.  Several motifs are also marked. C. The 
hexameric structure of the mtMCM N-terminal region. Colors are as in panel B. 
 
 The Phe residue, which is mutated in MCM4Chaos3, is not only conserved in 
the eukaryotic MCM4 proteins but also in the archaeal MCM protein (Fig. 
2.1B).  Thus, the MCM homologue from the archaeon M. thermautotrophicus 
(mtMCM) was chosen to study the effect of MCM4Chao3 mutation on MCM 
functions.  It has been found that the complex formed using the mutant MCM is 
less stable in comparison to the wild-type enzyme and has reduced helicase 
activity. The data presented here provide an explanation for the observations 
made with the mutant mice.  
 
2.3 Materials and Methods 
2.3.1 Materials 
 ATP and [γ-32P]ATP were purchased from GE Healthcare, and 
oligonucleotides were synthesized by the CARB DNA synthesis facility. 
The ROX labeled DNA was purchased from Integrated DNA technologies. 
The wild-type full-length mtMCM construct was original from Prof. Zvi 
  21 
Kelman’s lab (Institute for Bioscience and Biotechnology Research, 
University of Maryland). 
 
2.3.2 Proteins expression and purification 
 The full-length MCM proteins harboring the Phe172 to Ile (F172I) 
and the Phe172 to Val (F172V) substitutions were generated by Dr. John 
Schimenti laboratory using QuickChange Site-Directed Mutagenesis Kits 
(Stratagene) using the wild-type full-length MCM in the pET-16b vector 
(Novagen) (23) as a template. All constructs contain a N-terminal His10-
tag. All proteins were expressed in Escherichia coli BL21-DE3 cells at 
24°C and induced with IPTG at a concentration of 1.0 mM. Proteins were 
expressed in E. coli cells BL21(DE3) at 37°C in the presence of 
appropriate antibiotics. When the culture reached an A 600 of 0.6, protein 
expression was induced by incubation in the presence of 1.0 mM IPTG 
overnight at 24°C after which time the cells were harvested. Cell lysates 
were prepared by sonication in lysis buffer containing 20mM Tris-HCl 
(pH 8.0), 500mM NaCl, 5mM Imidazole, 10% glycerol and protease 
inhibitor cocktail (containing Pepstatin A, Leupeptin, PMSF, and 
Benzamidine). After centrifugation for 30 min at 13000 rpm, extracts were 
incubated with Ni-NTA agarose column (Qiagen) for 2 h at 4 °C and 
washed with 10 column volumes of washing buffer (20mM Tris-HCl (pH 
8.0), 500mM NaCl, 10% glycerol and protease inhibitor cocktail) 
containing 10 mM imidazole, and then 5 column volumes of Washing 
Buffer containing 100 mM imidazole. Then targeted proteins were eluted 
from the column with 5 column volumes of Elution Buffer (Washing 
Buffer containing 500 mM imidazole).  
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 The wild-type or F172I mutant of the N-terminal part of mtMCM 
(residues 2–286) were cloned into pGEX-4T-1 plasmid (Amersham) 
between the BamHI and XhoI sites, using the plasmids containing the wild 
type or F172I mutant genes as templates for PCR. The proteins were 
overexpressed in E. coli BL21-DE3 cells at 24°C.  The cells were lysed in 
buffer containing 50 mM Tris-HCl (pH 8.0), 250 mM NaCl and 10% 
glycerol and clarified by centrifugation.  The lysate was incubated with 
Glutathione Sepharose 4 fast flow resin (GE Healthcare).  Following 
extensive washing with same buffer, the proteins were cleaved from the 
resin using thrombin at 4°C in buffer containing 20 mM Tris-HCl (pH 
8.5), 150 mM NaCl, and 2.5 mM CaCl2.  The flow through was collected, 
concentrated and purified on Superdex-200 column (GE Healthcare). 
 All purified proteins used for the study were extensively dialyzed 
against buffer containing 20mM Tris-HCl (pH 8.0), 100mM NaCl, 0.5mM 
EDTA, 4mM DTT, and 10% glycerol.  Protein concentrations were 
determined with Bradford (Bio-Rad) with bovine serum albumin (BSA) as 
the standard. Proteins were aliquoted, flash-frozen in liquid nitrogen and 
stored at -80°C.  
 
2.3.3 Gel filtration analysis 
 The Gel filtration analysis of the full-length mtMCM wild-type and 
mutant proteins were performed at 25°C using Superose-6 gel filtration 
column (GE Healthcare) with buffer containing 50 mM Tris (pH 8.0), 250 
mM NaCl, and 10% Glycerol. Prior to analysis the proteins were diluted to 
a concentration of 1mg/ml and incubated for 16 hr at 25°C. 150 µl samples 
were fractionated on the column. 
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 The gel filtration of the N-terminal part of the wild-type and mutant 
mtMCM proteins were performed at 4°C using a Superdex-200 gel 
filtration column (GE Healthcare) with buffer containing 50 mM Tris (pH 
8.0), 250 mM NaCl, and 10% Glycerol. Prior to analysis the proteins were 
diluted to a concentration of 2mg/ml and incubated for 16 hr at 4°C. 150 µl 
samples were fractionated on the column. (The gel filtration experiments 
of the N-terminal proteins were also performed in exactly the same 
conditions as full-length proteins, in which the results are consistent to the 
conditions listed above. The data presented in this thesis was under the 
conditions described above.) 
 
2.3.4 Light scattering 
 The solution molecular masses of both proteins were determined 
using size exclusion chromatography with in-line multi angle light 
scattering. A 1200 series HPLC system (Agilent Technologies, Santa 
Clara, CA, USA) with a Shodex KW-802.5 column (Showa Denko K.K., 
Japan) was used to separate components of the solutions.  The flow rate 
was 0.5 ml/min and the mobile phase was 0.01 M phosphate buffer (pH 
6.5), 0.1 M ammonium sulfate, 0.1 mM EDTA and 0.01 % sodium azide.  
The light scattering was measured with a miniDawn Treos (Wyatt 
Technology, Santa Barbara, CA, USA); the protein concentration was 
measured with an Optilab rEX differential refractometer (Wyatt 
Technology, Santa Barbara, CA, USA).  The proteins were diluted with the 
column buffer to the final concentration of 11 mg/ml (wild-type N-
mtMCM) and 13 mg/ml (F172I N-mtMCM).  20 µl of each protein was 
used for the analysis. Molecular weights were calculated using Wyatt's 
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ASTRA software.  
 
2.3.5 Circular dichroism  
   Circular dichroism (CD) measurements were performed with a 
Model J-720 Jasco Spectropolarimeter using quartz cells with a 0.005 cm 
path length at 24°C. The proteins used for CD were prepared as described 
above with concentrations of proteins ranging from 10-30 mM.  Far-UV 
wavelength scans were recorded at room temperature from 260 to 200 nm.  
Averages for three CD spectra were presented. Ellipticity results were 
expressed as mean residue ellipticity[θ] = degrees x centimeter2 x 
decimole-1. 
 
2.3.6 Helicase assay 
a) Preparation of substrates for Helicase Assays 
 Substrates for helicase assays were generated as described below 
(following standard procedures referred in (24) ) using the DF25 (5′-
CCGACGTGCCAGGCCGACGCGTCCC-3′) and DF50 (5′-
GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCAGGCACC
CGATGGC-3′) oligonucleotides to make the flat substrate and DF61 (5′-
TTTGTTTGTTTGTTTGTTTGTTTGTTTGTTTGTTTGCCGACG 
TGCCAGGCCGACGCGTCCC-3′) and DF74 (5′-
GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCAGGCACC
CGATGGCGTTTGTTTGTTTGTTTGTTTGTTT-3′) oligolucleotides to 
make the forked substrate.   
 The helicase substrates were made by labeling one DNA strand of 
each oligonucleotides at the 5' end using [γ-32P]ATP with T4 
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polynucleotide kinase and adding EDTA of a final concentration of 25 mM 
to stop the labeling reactions. The labeled oligonucleotide was hybridized 
to the other oligonucleotide (usually at a 1:1 molar ratio) in a buffer 
containing 40 mM Hepes-NaOH (pH 7.5) and 50 mM NaCl by heating to 
100 °C for 3 min followed by slow cooling to 25 °C. Unincorporated [γ-
32P]ATP and unannealed oligonucleotides were removed using the 
following procedure. After hybridization, a 6x loading buffer (0.1% xylene 
cyanol, 0.1% bromophenol blue, and 50% glycerol) was added to a final 
concentration of 1x, and the mixture was electrophoresed through an 8% 
native polyacrylamide gel for 1 h at 100 V in 0.5x TBE (45 mM Tris, 4.5 
mM boric acid, 0.5 mM EDTA). The desired substrates were located by 
autoradiography, and the products were excised from the gel, which was 
sliced into small pieces and incubated at 37 °C for 2 h in 3 volumes of an 
elution buffer containing 0.5 M ammonium acetate, 10 mM magnesium 
acetate, 1 mM EDTA (pH 8.0). After centrifugation, the supernatant was 
collected, and the insoluble material was extracted once more with elution 
buffer. Following centrifugation, both supernatant fractions were 
combined, and DNA substrates were then ethanol precipitated and 
dissolved in TE (10 mM Tris-HCl (pH 7.5), 1 mM EDTA). 
 
b) DNA Helicase assay 
 DNA helicase activity assays were measured in reaction mixtures (15 
ml) containing 20 mM Tris-HCl (pH 8.5), 2 mM DTT, 10 mM MgCl2, 100 
mg/ml bovine serum albumin (BSA), 3.33 mM ATP, 10 fmol (0.66 nM) 
(as monomer) of 32P-labeled substrate and 10, 30 or 90 ng of full-length 
mtMCM wild-type or mutant proteins. Following incubation at 60°C for 1 
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hr the reactions were stopped by adding 5 ml of loading buffer containing 
1% SDS, 100 mM EDTA, 0.1% xylene cyanol, 0.1% bromophenol blue 
and 50% glycerol. Aliquots (10 ml) were loaded onto an 8% native 
polyacrylamide gel in 0.5x TBE (44.5mM Tris, 44.5mM boric acid and 1 
mM EDTA) and electrophoresed for 40 min at 180V. Gels were visualized 
and quantitated by phosphorimaging. All helicase experiments were 
repeated three times, and their averages with SD are shown in the figure. 
 The doping experiment was performed as described above with the 
flat substrate using 90 ng of wild-type MCM and mutant proteins in ratios 
of 1:5, 3:3, 5:1 and 6:0.  Experiments were repeated three times, and their 
averages with SD are shown in the figure.  
 
2.3.7 Statistical Model for Doping Assay 
 Addition of mutant protein to reaction allows the formation of 
hetero-oligomers between the WT and mutant enzymes. The relative 
abundance of each species should follow a binomial distribution if non-
cooperative binding properties are obtained between two forms of 
mtMCMs. So Equation (1) was used to calculate the possibility of each 
hexameric species present in the reaction mixture at any given ratio of 
wild-type and mutant protein, where “p” is the proportion of the amount of 
wild-type protein out of total amount of proteins; “x” is the number of 
wild-type protein molecule in a hexamer, which can take value of 
0,1,2,3,4,5,6; then the equation describing the distribution of X is, 
 
                                                       (1) 
! 
Pr(X = x) = x
6" 
# 
$ % 
& 
' px 1( p( )6 ( x
  27 
This equation is only true when 0<p<1.  If there is only wild-type protein 
in the reaction, then Pr(X=6)=1, and Pr(X=0)=Pr(X=1)=Pr(X=2)=Pr(X=3) 
=Pr(X=4)=Pr(X=5)=0; If there is no wild-type protein in the reaction 
(mutant protein only), then Pr(X=0)=1, and Pr(X=1)=Pr(X=2)=Pr(X=3)= 
Pr(X=4)=Pr(X=5)= Pr(X=6)=0. 
 
2.3.8 ATPase assay 
 ATPase activity was measured in reaction mixtures (15 µl) 
containing 25 mM Hepes-NaOH (pH 7.5), 1 mM dithiothreitol, 5 mM 
MgCl2, 100 µg/ml BSA, and 1500 pmol of [γ-32P]ATP (3000 Ci/mmol; GE 
healthcare) and 30 or 90 ng full-length mtMCM wild-type and mutant 
proteins in the absence or presence of 50 ng ssDNA (5'-
GGCAGATAACAGTTGTCCTGGAGAACGACCTGGTTGACACCCTC
ACACCC - 3'). After incubation at 60°C for 60 min, samples were placed 
on ice, then an aliquot (1 µl) was spotted onto a polyethyleneimine 
cellulose thin layer plate, and ATP and Pi were separated by 
chromatography in 1 M formic acid and 0.5 M lithium chloride. The extent 
of ATP hydrolysis was quantitated by phosphorimager analysis. All 
ATPase assays were repeated three times, and their averages with SD are 
shown in the figure. 
 
2.3.9 DNA binding assay 
 Fluorescence anisotropy measurements were performed at 25°C 
using a Varian Cary Eclipse Spectrofluorometer equipped with an 
autopolarizer in a L-format, using a 10 mm path length cuvette with a 
starting volume of 1 ml. A 50-mer ssDNA (5'
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CGCAGATAACAGTTGTCCTGGAGAACGACCTGGTTGACACCCTC
ACACCC-3') labeled at the 5'-labeled with ROX was used for the study. 
The initial reaction mixture contained 25 mM Hepes-NaOH (pH 7.5), 2 
mM DTT, 5 mM MgCl2 and 30 nM DNA. After each addition of proteins, 
the anisotropy value was monitored for 10-15 minutes until it reach the 
equilibrium. Each reading was measured with a setting of 10 sec 
integration. An average of several readings in equilibrium was recorded as 
the anisotropy value at each protein concentration. The DNA was excited 
at 588 nm and emission spectrum was set at 608 nm. The G-factor was 
acquired once at the beginning of each experiment.  
 The binding constant (Kd) was determined using GraFit version 5.0.1 
(Erithacus software), using the following equation for fluorescent 
polarization anisotropy experiments [17,18]; where A is the change in 
anisotropy, AT is the total anisotropy change, E is the enzyme 
concentration at each titration point, DT is the total concentration of DNA 
(assuming it is constant at 30 nM), Kd is the dissociation constant for the 
binding isotherm and nH is the fitted Hill coefficient. The experiments 
were repeated twice and their averages with SD are shown in the figure.  
 
                               (2) 
 
2.3.10 Energy minimization  
 A Hexameric wild-type N-terminal model was constructed from the 
crystal structure of wild-type mtMCM (Ref. 15, PDB code: 1LTL). 
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Hexameric F172I and F172V mutants were built by changing Phe172 to 
Ile172 and Val172, respectively. As the side chains of Ile and Val residues 
are shorter than that of Phe, they were visually modeled to conformations 
with least close contacts to surrounding atoms and with maximum overlaps 
over the phenyl ring of Phe. To further remove possible close contacts 
introduced by the manual manipulation, conjugate-gradient energy 
minimization implemented in the program CNS (version 1.2) (37,38) was 
performed on the hexameric wild-type as well as mutant models. 
Calculations converged after 200 steps of energy minimization. To 
determine the structural impact by the F172I/F172V mutations on the 
hexameric assembly of mtMCM, residue 172 and four closest residues 
(Ser103, Ile106, Thr222, and Phe231) were extracted from its neighboring 
monomer for detailed energy analysis. Energy for each of the five-residue 
models described above was calculated by using CNS and was compared 
with each other as shown in the figure. 
 
2.3.11 Processivity assay 
 Three forked substrates with increasing duplex lengths (Suppl. Table 
1A,B,C) were generated and used for helicase assay as previously 
described, to investigate the processivity ability of full-length wild-type 
and mutant helicases. 6% native polyacrylamide gels were used for 
electrophoresis to display wound and unwound substrates. Experiments 
were repeated three times, and their averages with SD are shown in the 
figure.  
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2.3.12 TrpY protein replacement assay 
 This assay was performed by Nozomi Sakakibara. A helicase 
substrate containing the regulatory region, including the four TRP-box 
sequences, from upstream of the M. thermautotrophicus trpEGCFBAD 
operon (Suppl. Table 1D) was used for unwinding assay. The ability of 
full-length wild-type and mutant helicases to unwind this DNA substrate 
were assayed when protein-free or bound by TrpY. Each protein was 
assayed at two different concentrations, 50ng and 150ng per reaction. 
TrpY binding substrate was prepared and helicase assays were done as 
previously described (36). Experiments were repeated three times, and 
their averages with SD are shown in the figure. 
 
2.4 Results 
 
2.4.1 Phe172 is needed for efficient helicase activity. 
 
  The MCM complex is thought to function as the replicative helicase in 
archaea and eukarya. Thus, although the mice harboring the Chaos3 
mutation are viable, they show an increase in chromosomal instability 
suggesting a defect in DNA replication (5,6). To determine how the 
Chaos3 mutation affects MCM helicase activity the conserved Phe residue 
(Phe172) was substituted with either Ile or Val in the mtMCM protein 
(Fig. 2.2).  When a forked DNA substrate containing both 3’ and 5’ 
overhang ssDNA was used, the mutants and wild-type enzymes exhibit 
similar helicase activity (Fig. 2.2A compare lanes 6-11 to lanes 3-5, see 
also panel B).  As mice harboring the MCMChaos3 mutation are viable, one 
would expect the enzyme to retain some activity (all six Mcm2-7 proteins 
are essential for viability). It was previously shown that the archaeal MCM 
  31 
proteins, including mtMCM, were more active on forked substrate 
compared to substrate that contains only a 3’-overhang ssDNA region (flat 
substrate) (27). Thus, a flat substrate was also used to determine the effect 
of the mutations as it may indicate impaired activity. As shown in Figure 
2.2 C and D, while the substitution of Val for Phe does not have a major 
effect on helicase activity (Fig. 2.2C compare lanes 9-11 to lanes 3-5, see 
also panel D), the Phe to Ile substitution resulted in very limited helicase 
activity compared to the wild-type enzyme (Fig. 2.2 compare lanes 6-8 to 
lanes 9-11, see also panel D).  As a control, a mutant protein harboring a 
mutation of a conserved Lys needed for ATP binding and hydrolysis 
(K325A) was used. This mutant was previously shown to be devoid of 
helicase activity (28,29) as is also found here (Fig. 2.2C lane 12).  These 
results suggest that the in vivo observation made with the Chaos3 
mutation is due to impaired helicase activity by the helicase. 
       
 
Figure 2.2 mtMCM with Ile substitution for Phe at position 172 exhibits impaired 
helicase activity.  Helicase assays were performed as described in “Materials and 
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Methods” using 10 fmol of flat (A and B) or forked (C and D) substrate. Representative 
gels are shown in panels A and C and the summary of three independent experiments 
with standard deviation are shown in panels B and D.  In panels A and C lane 1, substrate 
only; lane 2, boiled substrate; lanes 3, 6 and 9, 10 ng of proteins; lanes 4, 7 and 10, 30 ng 
of proteins; lanes 5, 8, 11 and 12, 90 ng of proteins.  Lanes 3-5, wild-type mtMCM 
protein; lanes 6-8, F172I mutant mtMCM protein; lanes 9-11, F172V mutant mtMCM 
protein; lane 12, K325A mutant mtMCM protein. 
 
Another approach to demonstrate that the F172I mutation impairs 
helicase activity is by performing a doping experiment.  In this assay, the 
ratio between the wild-type and mutant proteins decreases in each 
reaction, resulting in heterocomplexes with different proportions of wild-
type and mutant protein.  If a mutant subunit affects the overall helicase 
activity then as the ratio between the mutant and wild-type protein 
increases in the assay, the enzyme will become less active.  The addition 
of F172V to wild type protein did not have a major effect on the helicase 
activity (Fig. 2.3), as expected from the helicase activity of the mutant 
protein alone (Fig. 2.2).  In contrast, the formation of heterocomplexes 
containing subunits of the F172I mutant and wild type proteins resulted in 
a substantial reduction in helicase activity (Fig. 2.3). Consistent with the 
helicase assay results of Figure 2.2, the mutant enzyme retained ~5% of 
helicase activity even when only the mutant protein was used. However, 
reduction in activity was evident when the ratio between the wild type and 
mutant protein (F172I) was 5:1 suggesting that a single mutant protein in 
the hexameric ring may be sufficient to affect helicase activity. 
 If one assumes free exchange between hexamers, the number of 
hexamers that contain only wild-type proteins should follow a binomial 
distribution. Therefore, when the ratio between wild-type and mutant is 
5:1, 33.5 percent of hexamers should contain only wild-type proteins and 
1.5 percent when the ratio is 3:3. Given the maximum wild-type 
unwinding data of 55% and assuming that a single Walker-A mutant 
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protein complex with 5 wild-type enzymes will abolish helicase activity, 
one would expect 18.5% and 1% unwinding when the ratios between wild-
type and mutant protein (K325A) are 5:1 and 3:3, respectively.  This is not 
the case, however, higher activity was observed (Fig. 2.3).  If both the 
wild-type and mutant proteins were added to the reaction as stable 
hexamers, then it is possible that an hour of incubation was not sufficient 
to reach equilibrium.  It is also possible that one subunit of the hexamer 
containing a Walker-A mutant is not sufficient to abolish helicase activity, 
as was suggested for S. solfataricus (30). In comparison with the 
observations made with the K325A mutant, the reduction in helicase 
activity by the F172I mutant protein is less dramatic, suggesting F172I is a 
milder mutation than K325A. 
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Figure 2.3 mtMCM F172I mutant protein inhibits helicase activity when complexed 
with the wild-type enzyme. Helicase assays were performed as described in “Materials 
and Methods” using 10 fmol of flat substrate and 90 ng of protein. A representative gel is 
shown in panel A and the result of three independent experiments with standard deviation 
is shown in panel B.  In panel A lane 1, substrate only; lane 2, boiled substrate; lane 3, 
wild-type only; lanes 4, 8 and 12, the ratio between the wild-type and mutant proteins is 
5:1; lanes 5, 9 and 13, ratio of 3:3; lanes 6, 10 and 14, ratio of 1:5; lanes 7, 11 and 15, 
mutant protein only.  Lanes 4-7, F172I; lanes 8-11, F172V; lanes 12-15, K325A.  
  
In eukarya the active helicase is a heterohexamer in which only one 
copy of MCM4 is present.  Therefore there is only one MCM4Chaos3 
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mutant protein in each helicase.  The data presented in Figure 2.3 suggest 
that the presence of even one mutant protein in the hexameric ring is 
sufficient to reduce helicase activity.  This observation may explain why a 
mutation in a single MCM in eukarya is sufficient to affect helicase 
activity. 
 
2.4.2 Phe172 is required for efficient DNA binding by MCM 
 
 An active helicase binds DNA and translocates along it in an ATP-
dependent manner. The experiments described above (Fig. 2.2 and 2.3) 
demonstrate that the F172I mutant protein has impaired helicase activity.  
The impaired activity can be a result of reduced affinity to DNA and/or 
reduced ATPase activity by the helicase. Therefore, to get a better 
understanding of the Chaos3 mutation, the mutant proteins (F172I and 
F172V) were evaluated for their ability to bind DNA and to hydrolyze 
ATP.  
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Figure 2.4 Mutations of Phe 172 do not significantly affect DNA binding by 
mtMCM. The Kd values of the interactions between mtMCM wild-type and mutant 
proteins and DNA were measured using Fluorescence polarization anisotropy (FPA) 
analysis as described under “Materials and Methods” in the presence of 30 nM Rox-
labeled ssDNA.  The anisotropy change was measured as the proteins were titrated into 
the reaction mixture.  Panel A, full-length enzyme; panel B, N-terminal part of the 
molecule.  Data were analyzed as described in “Materials and Methods” and the Kd 
values are shown in panel C.     
 
 Although mtMCM interact with DNA mainly via the N-terminal part 
of the molecule (15,17,18) it was shown that the catalytic domain also 
participates in DNA binding (31).  Thus the ability of the mutation in the 
full-length protein (Fig. 2.4A) or the N-terminal part (Fig. 2.4B) to bind 
DNA was determined.  As expected, the wild-type full-length enzyme 
binds DNA with higher affinity (Kd of 42nM) in comparison to the N-
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terminal part alone (Kd of 82nM) (Fig. 2.4C). When the mutations are 
presence in the full-length background both enzymes (F172I and F172V) 
bind ssDNA with slightly lower affinities (Kd of 110 and 140nM, 
respectively) in comparison to the wild-type enzyme (Fig. 2.4A and 2.C). 
Similarly, the F172I mutation on the background of the N-terminal part of 
the molecule also resulted in reduced affinity to ssDNA (Kd of 243nM) 
(Fig. 2.4B and 2.C). However, the reduced affinity is rather small and 
similar in both mutant (Kd of 138 and 111 for F172I and F172V, 
respectively) and thus this reduction is unlikely to affect helicase activity 
observed with F172I (Fig. 2.2 and 2.3).  The minimal effect of mutation 
on DNA binding is not unexpected as Phe172 is not located near the 
motifs involved in DNA binding (the zinc-finger and β-hairpin motifs) 
(Fig. 2.1A) (15,17,18).   
 
      
Figure 2.5 Mutations of Phe 172 reduce ATPase activity by mtMCM. ATPase activity 
of wild-type and mutant mtMCM proteins in the absence and presence of ssDNA was 
determined as described in “Materials and Methods” using 30 and 90 ng of proteins (as 
monomer) in the absence (lanes 1-7) or presence (lanes 4-14) of 50ng of 50 mer ssDNA. 
A representative gel is shown in panel A; the summary of three independent experiments 
with standard deviation is shown in panel B. 
 
 Next, the ability of the mutant protein to hydrolyze ATP was 
determined. Although the mutations are at the N-terminal part of the 
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molecule and not in the AAA+ catalytic domains it was shown that 
mutations at the NCL of the N-terminal part of MCM affect the ATPase 
activity of the catalytic region (20,21).  As shown in Figure 2.5 both 
mutant proteins (F172I and F172V) exhibit some reduction in basal 
ATPase activity compared to the wild-type MCM protein (Fig. 2.5B).  
However, DNA stimulates the ATPase activity of both mutant proteins to 
the same extent as the stimulation of the wild-type enzyme (Fig. 2.5). The 
reduced ATPase activity of the F172I mutant protein may account for the 
reduced helicase activity. The reduced ATPase activity, however, cannot 
explain the difference in helicase activity observed on forked and flat 
substrates (Fig. 2.2).  Thus, it is unlikely that the effect of the Chaos3 
mutation on helicase activity is via reduction in DNA binding and/or 
ATPase activity by the mutant enzymes. 
 
2.4.3 Phe172 participates in MCM hexamerization. 
 
 In addition to affecting DNA binding and ATPase activities, mutation 
of Phe 172 may also affect the structure and oligomeric state of the protein 
which in turn may affect the enzymatic activity.  It is well established that 
the active helicase has a hexameric form ((32) and references therein). 
Thus, it is possible that the F172I mutation affects the structure or stability 
of the hexameric ring.  Phe172 from one monomer is in close proximity to 
the neighboring subunit (Fig. 2.1C) supporting the possibility of the 
mutation affecting hexamer integrity. To evaluate this possibility, gel-
filtration analyses of the full-length F172I and F172V proteins were 
performed (Fig. 2.6). It was found that the full-length versions of all three 
proteins form similar oligomeric structures (Fig. 2.6A).  However, in order 
to detect the protein on gel filtration, high protein concentrations (13 mM) 
were used.  It was shown that protein concentration plays a major role in 
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MCM oligomeric state (32).  One way to determine whether the structure 
of the mutant proteins is compromised even if high concentrations are 
used is to analyze only the N-terminal part of the molecule.  Biochemical 
and structural studies showed that the N-terminal part of the wild-type 
enzyme is hexameric (Fig. 2.6B) (15,22). 
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Figure 2.6 Mutations of Phe 172 affect the oligomeric structure of mtMCM. Gel-
filtration analysis of the full-length (A) or N-terminal part (B) of wild-type and mutant 
MCM proteins.  One hundred micrograms of protein were loaded onto a superose-6 (A) 
or superdex-200 (B) gel filtration column and analyzed as described in “Materials and 
Methods”.  
 
The F172I mutant, on the other hand, is monomeric (Fig. 2.6B) although 
the overall secondary structure was not changed (Fig. 2.7).  These results 
suggest that MCM proteins harboring the mutation form less stable 
hexamers in comparison to the wild-type enzyme.  
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Figure 2.7 Mutations of Phe172 does not affect the over all secondary structure of 
mtMCM. Circular dichroism (CD) spectra of wild-type and mutant mtMCM proteins.  
Each spectra was normalized to mean residue ellipticity [θ] = degrees x centimeter2 x 
decimole-1 according to the concentrations of protein determined as described in 
“Materials and Methods”.  The spectra were taken at 24°C.  
 
 Taken together, the results suggest that the substitution of Ile for Phe 
at position 172 affects the stability of the MCM hexamer and may 
contribute to its helicase activity. 
 
2.4.4 Structure simulation suggests a thermodynamically less stable 
model for F172I mutant protein 
 Another approach to evaluate the stability of the enzyme is by using 
energy minimization analysis, which can indicate the impact of the 
mutation on the structure. Three N-terminal mtMCM protein models 
(wild-type, F172I and F172V) were built as described in “Materials and 
Methods” (Fig. 2.8). Amino acid 172 and its four closest residues (Ser103, 
Ile106, Thr222, and Phe231) from the neighboring subunit were chosen for 
detailed energy analysis. By comparing the total energy of these three 5-
residue models, it was found that the model with F172I mutation has 
higher energy (-61.942 cal/mol) than the wild type protein (-80.885 
cal/mol), suggesting that it is thermodynamically less stable. The F172V 
model appears to have slightly lower energy (-93.589 cal/mol) than the 
wild type protein, which might explain their similar activity levels for all 
enzymatic reactions studied. Taken together, the results suggest that the 
substitution of Ile for Phe at position 172 affects the stability of the MCM 
hexamer and thus may contribute to the reduction of its helicase activity. 
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Figure 2.8 5-residue simulation model of N-terminal wild-type and mutant 
proteins. A) Wild-type 5-residue model. The distance between Phe172 and other 4 
residues are shown with red dot lines. B) F172I mutant 5-residue model. The distance 
between Ile172 and other 4 residues are shown with red dot lines. C) F172V 5-residue 
model, the distance between Val172 and other 4 residues are shown with blue dot 
lines. The units for the distances are all in Å. Total energy of each protein model was 
calculated based on the above coordinates. D) Total energy comparisons of three 5-
residue simulation models. The program CNS was used with one-step energy 
minimization to calculate the total energy of each model system. 
 
2.4.5 F172I mutation does not affect processivity activity  
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  The ability of both wild-type and mutant mtMCM proteins to process 
forked substrates with increased duplex regions was assayed. Results show 
that mutations of Phe172 do not apparently affect helicase processivity 
activity. All three proteins can unwind forked DNA substrates up to 80bp 
duplex length. But the helicase activity of F172I mutant protein does get 
weaker when the duplex region of forked substrate increases, which is 
consistent with the results on helicase assay with flat substrate. The effect 
of F172I mutation on forked substrate with 26bp duplex (Suppl. Table 1A) 
is hard to see (Fig. 2.9A compare lanes 6-11 to lanes 3-5, see also panel D), 
as it is discussed in helicase assay previously. But the helicase activity of 
F172I mutant was apparently reduced when 55bp duplex substrate (Suppl. 
Table 1B) was used (Fig. 2.9B compare lanes 6-11 to lanes 3-5, see also 
panel D), and the effect was even greater on 80bp duplex substrate (Suppl. 
Table 1C) (Fig. 2.9C compare lanes 6-11 to lanes 3-5, see also panel D). 
Although this assay does not provide enough information to tell a 
difference on processivity ability of all three proteins, it does confirm that 
the F172I mutation does reduce the enzyme’s helicase activity. 
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Figure 2.9 The processivity of mtMCM mutant helicase were not significantly 
affected. Mutant proteins can process forked substrate with up to 80 bp duplex, but the 
F172I mutant protein exhibits impaired helicase activity on long duplex forked substrates. 
Helicase assays were performed as described in “Materials and Methods” using three 
forked substrates with increasing duplex length. The substrate used for each assay was 
illustrated at the top of the figure with the location of the 32P-label identified by the 
asterisk. Representative gels of assays using forked substrate with 26bp, 55bp and 80bp 
duplex length are shown respectively in panels A, B and C and the summary of three 
independent experiments with standard deviation are shown in panels D.  In panels A, B 
and C lane 1, substrate only; lane 2, boiled substrate; lanes 3, 6 and 9, 10 ng of proteins; 
lanes 4, 7 and 10, 30 ng of proteins; lanes 5, 8, 11 and 12, 90 ng of proteins.  Lanes 3-5, 
wild-type mtMCM protein; lanes 6-8, F172I mutant mtMCM protein; lanes 9-11, F172V 
mutant mtMCM protein; lane 12, K325A mutant mtMCM protein. 
 
2.4.6 F172I mutation does not affect protein displacement activity 
 
 TrpY is a M. thermautotrophicus transcription repressor that binds 
specifically to TRP-box sequences (consensus TGTACA) that are located 
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upstream of the trpY, trpEGCFBAD, and trpB2 genes in the 
Methanothermobacter thermautotrophicus genome. The helicase substrate 
that contains 4 TrpY protein binding sites (Suppl. Table 1D) was therefore 
used to investigate the ability of mutant protein to replace TrpY and 
unwind the substrate (36).  
 
 
Figure 2.10 Mutations of Phe 172 do not affect protein displacement activity by 
mtMCM. The ability of the mutant mtMCMs to unwind DNA substrate was assayed as 
described in “Materials and Methods” using 50 ng and 150 ng of proteins (as monomer) 
with substrate protein-free (lanes 1-9) or TrpY bound (lanes 10-17). A representative gel 
is shown in panel A; the summary of three independent experiments with standard 
deviation is shown in panel B. In panel A, lanes 1 and 10, substrate only; lane 2, boiled 
substrate; lanes 3, 5, 7, 11, 13 and 15, 50 ng of proteins; lanes 4, 6, 8, 12, 14 and 16, 150 
ng of proteins.  Lanes 3-4 and 11-12, wild-type mtMCM protein; lanes 5-6 and 13-14, 
F172I mutant mtMCM protein; lanes 7-8 and 15-16, F172V mutant mtMCM protein; lane 
9 and 17, 150 ng of K325A mutant mtMCM protein. 
 
 
 Results show that protein displacement activity of either F172I or 
F172V mutant was not abolished. But as expected to be weaker helicases, 
the unwinding efficiency of F172I mutants were reduced with either 
substrate (Fig. 2.10A compare lanes 5-8 to lanes 3-4 for protein free 
substrate and lanes13-16 to lanes 11-12 for TrpY bound substrate, see also 
panel B). This result is consistent with the above experiments. Again, as a 
negative control, neither the TrpY-bound substrate nor the protein-free 
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substrate was unwound by the MCM (K324A) mutant that lacked helicase 
activity (Fig. 2.10, lane 17 and 9). 
 
 
2.5 Discussion 
 
In this study, the MCM protein from the archaeon M. 
thermautotrophicus was used as a model to study the mouse Chaos3 mutation.  
The mutation in the mouse MCM4 protein is a substitution of a conserved Phe 
residue with Ile.  Examination of the structure of the N-terminal part of mtMCM 
revealed that Phe172 is a part of a β strand (β7) located in domain C where it 
connects to domain B (Fig. 2.1) (15).  In the hexameric structure, Phe172 is 
located at the interface between neighboring monomers (Fig. 2.1C) (15).  The 
proximity of Phe172 from one monomer to another monomer in the hexameric 
structure suggests that the residue may play a role in hexamer formation.  In the 
wild-type MCM protein, the phenyl ring of Phe172 interacts with the phenyl ring 
of Phe231 of the neighboring monomer (Fig. 2.11) by an edge-face π overlap. 
This interaction is lost when Phe172 is mutated to Ile or Val. These results are 
also consistent with the previously reported observation that domain C, where 
Phe172 is located, is needed for mtMCM hexamerization (22). 
 
 
Figure 2.11 The role of residue 172 in hexamer formation. In the wild-type MCM protein, the 
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phenyl ring of Phe172 interacts with the phenyl ring of Phe231 of the neighboring monomer by 
an edge-face π overlap. This interaction is lost when Phe172 is mutated to Ile (A) or Val (B). 
 
The effect of the mutation on hexamer stability can also explain the 
observation that while little effect on mtMCM helicase activity was observed 
when analyzed on a fork-like structure with both 3’ and 5’ overhang regions, 
very limited activity was detected on substrate with only a 3’ overhang.  It was 
previously shown that when provided with a fork-like substrate the archaeal 
MCM complex encircling the 3’ ssDNA strand also interacted with the 5’ 
overhang ssDNA region (33).  Using the eukaryotic MCM complex it was 
shown that the processivity of the helicase is substantially increased when 
provided with a forked DNA substrate and it was shown that the helicase 
interacts with both single stranded strands (34).  Thus, it is likely that although 
the hexamers harboring the F172I mutations are less stable the additional 
interactions with both ssDNA at the fork-like substrate enhances the number of 
contacts between the helicase and DNA thus enables the enzyme to unwind the 
duplex. This additional stabilization is missing in the flat substrate.   
It was observed that in mouse cells harboring the Chaos3 mutation the 
stability of MCM4 and other MCM proteins was reduced (5).  This may also 
result from reduced stability of the mutant MCM molecule.  Studies have shown 
that in vivo most of the MCM proteins are part of complexes involving either all 
six proteins or several subsets of the proteins (for example see: (35)).  Thus, it is 
possible that these complexes are protected from degradation.  When the mutant 
MCM4 is expressed in vivo the complexes formed are less stable and thus may 
be more prone to degradation.  
The data presented here suggest that the MCM complexes containing 
the MCM4Chaos3 protein are less stable, providing a possible explanation for the 
observations made with mice harboring the mutation.  It remains to be 
determined, however, why the most severe effect of the mutation is observed in 
females and how the lowered helicase activity and reduced stability of the 
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complex observed with the mutant enzyme results in chromosomal instability. 
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Supplementary Table 1.  Sequences of substrates used in Processivity and TrpY 
replacement assays. Shaded boxes in A), B) and C) indicate complimentary 
sequences; in D) indicates TrpY protein binding sites and all the labeled strands are 
marked with asterisks.  
 
A) 26 bp duplex (DF61/DF74) 
DF61: 
*5′TTTGTTTGTTTGTTTGTTTGTTTGTTTGTTTGTTTGCCGACGTGCCA
GGCCGACGCGTCCC-3′ 
DF74:  
5′GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCAGGCACCCG
ATGGCGTTTGTTTGTTTGTTTGTTTGTTT-3′ 
 
B) 55 bp duplex (Trp98/Trp99) 
Trp98: 
*5’TACATATACACGGAGGTACTATTTAAATCTTGTCTGTATAATAAT
GTACACTAAGTTT(GTTT)10-3’ 
Trp99: 
5’GTCCTACGCTAATCTAAGCCGTTTACTCGCGATTTTGAAAATAGCT
TAGTGTACATTATTATACAGACAAGATTTAAATAGTACCTCCGTGTA
TATGTA-3’ 
C) 80 bp duplex (PB18/PB19) 
PB18: 
*5’TCAACCGTAATGGTGTTGTCCTACGCTAATCTAAGCCGTTTACTC
GCGATTTTGAAAATAGCTTAGGTGGAGATCTGATATTTGTTTGTTTG
TTTGTTTG-3’ 
PB19: 
5’TTTGTTTGTTTGTTTGTTTGTATCAGATCTCCACCTAAGCTATTTTC
AAAATCGCGAGTAAACGGCTTAGATTAGCGTAGGACAACACCAGT
ACGGTTGA-3’ 
D) TrpY binding substrate 
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CHAPTER 3 
STRUCTURAL STUDIES OF N-TERMINAL F172I MUTANT MTMCM USING 
SMALL-ANGLE  
X-RAY SCATTERING (SAXS) METHOD 
 
3.1 Introduction 
 Small-angle scattering of X-rays (SAXS) is a fundamental tool for 
structural analysis of biological macromolecules in solution, with sizes 
ranging from a few kilo-Daltons to several mega-Daltons. It does not require 
special sample preparation, which enables analysis of biological 
macromolecules and their complexes in nearly physiological environments 
and direct study of structural responses to changes in external conditions, 
such as large conformational transitions, assembly or unfolding processes, or 
intermolecular interactions.  
 In a scattering experiment, the solution contains macromolecules is 
exposed to X-rays (wavelength 0.1-0.2 nm), and the scattered intensity, I(s), 
is recorded as a function of the scattering angle (the angle between the 
incident and scattered radiation). Scattering intensity from a dilute 
monodisperse solution of macromolecules (e.g., of purified proteins) is 
proportional to the spherically averaged single-particle scattering: 
I(s) = 〈A2(s)〉Ω                           (1) 
where s=(s, Ω) is the scattering vector, s=(4π/λ)sin2θ, λ is the wavelength, 
and 2θ is the scattering angle (1). Only a few particle parameters (radius of 
gyration Rg, particle volume) are directly obtained from the SAXS data. 
Additional information about the particle structure is provided by contrast 
variation (2). The contrast of a particle or its component with a scattering 
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density distribution ρ(r) in a solvent of density; ρs is the average effective 
density Δρ=〈ρ(r)〉−ρs. For single-component macromolecules (e.g., proteins), 
measurements at different ρs allow extraction of the scattering due to the 
particle shape.  
 
 At low angles (resolution of 2 to 3 nm), as x-rays are insensitive to the 
internal structure, the scattering is essentially determined by the particle 
shape. Low-resolution shape models were thus constructed on a trial-and-
error basis using structural information from other methods. Recently, ab 
initio modeling approaches have been developed for low-resolution shape 
restoration representing the shape either by an angular envelope function 
(3,4), or as an ensemble of densely packed beads (1,5,6), and annealing 
simulation is employed to fit the scattering data. 
 In the first general ab initio approach, an angular envelope function of the 
particle, r=F(ω), where (r,ω) are spherical coordinates, is described by a 
series of spherical harmonics. The low-resolution shape is thus defined by a 
few parameters, the coefficients of this series, that fit the scattering data (2). 
This approach was further developed and implemented in the computer 
program SASHA (4). It was demonstrated that, under certain circumstances, 
a unique envelope can be extracted from the scattering data.  
 Use of the angular envelope function was, however, limited to relatively 
simple shapes. A more comprehensive description is achieved in the bead 
methods (1,5), which use the trial-and-error Debye modelling. A sphere with 
diameter of maximum particle size, Dmax, which is directly determined 
from the scattering data, is filled with M densely packed beads. Each bead 
belongs either to the particle (index=1) or to the solvent (index=0), and the 
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shape is thus described by a binary string of length M. Starting from a 
random distribution of 1s and 0s, the model is randomly modified using a 
Monte Carlo-like search to find a string X to fit the experimental data. As the 
search models usually contain thousands of beads, the solution must be 
constrained. In the simulated annealing procedure implemented in the 
program DAMMIN, an explicit penalty term P (X) is added to the goal 
function f (X) = χ 2 + P (X) to ensure compactness and connectivity of the 
resulting shape. Instead of using Debye’s formula, the intensity is computed 
with spherical harmonics to speed up the computation (7). 
 The assumption of particle homogeneity is a severe limitation of dummy 
atom models. For single component particles and a single scattering curve, 
the procedure degenerates to ab initio shape determination as implemented in 
DAMMIN (2). A more versatile approach to reconstruct protein models from 
SAXS data has recently been proposed, where the protein is presented by an 
assembly of dummy residues (DRs) and simulated annealing is used to build 
a locally ‘chain compatible’ DR model inside a sphere with a diameter of 
Dmax. Compared to ab initio shape determination, DR modelling 
(implemented in the program GASBOR) employs fewer free parameters to 
account for more experimental information (7). 
 In spite of the limited resolution and the restricted range of application, a 
number of successful studies have shown that solution scattering data 
provide sufficient information to restore particle shapes ab initio. 
 In this chapter, Small-angle scattering of X-rays (SAXS) was employed to 
examine mtMCM proteins using the existing N-terminal crystal structure as 
a priori information. Preliminary structural information obtained by this 
experiment will be discussed in Section 3.5. 
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3.2 Materials and Methods 	  
3.2.1 Materials 
 All mtMCM proteins used in this study were purified as previously 
described in Chapter II. All mtMCM proteins were further diluted with the 
same storage buffer (50mM Tris-HCl pH 8.0, 250mM NaCl) for SAXS 
experiment needs. BSA from Sigma was dissolved in 50 mM Hepes buffer 
with pH7.5 to 50 mg/ml. Lysozyme was dissolved to 50mg/ml in buffer 
containing 150mM NaCl, 40mM Na acetate (pH 3.8).  To remove high 
molecular weight protein aggregates from solution, all protein samples were 
centrifuged at 10 000 rpm for 10 min prior to beam exposure at 4°C. The 
upper clear liquids were kept for further x-ray scattering experiments.  	  
3.2.2 Small-angle x-ray scattering experiment  
 SAXS data were collected at 277 K at the Cornell High Energy 
Synchrotron Source (CHESS) G1 Station. The scattered signals were 
detected using a Finger lakes CCD detector. At a sample-to-detector distance 
of both 1430mm and 525mm and an X-ray wavelength of 1.247 Å, the 
scattering vector s (s = 4πsinθ/λ, where 2θ is the scattering angle) ranged 
from 0.01 to 0.5 Å-1, which was calibrated using Silver Behenate as a 
standard oriented specimen. Protein samples were encapsulated in a 20µl 
volume sandwiched between two thin parallel mica windows 1 mm apart. 
This sample cell is designed especially for protein SAXS experiments to 
reduce radiation damage and sample volume as previously described (8). 
Protein samples were injected into the sample cell, which was placed in a 
holder maintained at 4°C during all SAXS measurements. Data collected for 
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10 s exposures at each spot of a 2D matrix with a spatial interval of 0.6 mm 
on protein samples to reduce radiation-induced protein damage. Buffer and 
samples were collected alternatively to reduce error caused by protein 
aggregations (9). SAXS data were collected at protein concentration 2, 4, 6, 
8, 10, 15, 19.3 (mg/ml) for N-terminal mtMCM F172I mutant protein. For 
each concentration, SAXS data were collected at least twice. 	  
3.2.3 	  SAXS data analysis	  
This part of work was done by Xinguo Hong. The overall shapes of the 
proteins were restored from the experimental data by two independent 
programs, DAMMIN and GASBOR.	  	  
3.3 Preliminary Results and Discussion 
 
  The SAXS experiments of mutant N-mtMCM (F172I) protein show 
that the protein conformation is concentration dependent. At low 
concentration (~2mg/ml in my experiment), the protein was shown to form 
dimers in solution (Fig. 3.1).  
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Figure 3.1 GASBOR model of mutant N-terminal mtMCM (F172I) from SAXS data 
at 2mg/ml protein concentration. Model was generated using GASBOR program fitted 
by coordinates from published wild-type N-mtMCM protein crystal structure pdb file. 
Color balls stands for molecular surface of GASBOR model; blue and green ribbons 
stand for two monomers of N-terminal mtMCM from crystal structure. a) Side view of 
dimer model; b) Side view rotated 90 degree along Y axis; c) Top view of dimer model. 
 
At concentrations ≥ 4mg/ml. the protein favors a hexameric 
conformation (Fig. 3.2), but not with a ring structure. The six monomers 
arrange into a “L” like shape, which is consistent with the N-mtMCM 
asymmetric unit crystal structure, but definitely different from the 
reported double-hexamer structure. If this significant conformational 
change is true, the destabilized MCM4 protein in CHAO3 might has 
similar changes, and it may give us some ideas about the chromosomal 
instability caused by this mutation in mice.     
  59 
                                    
 
Figure 3.2 GASBOR model of mutant N-terminal mtMCM (F172I) from SAXS data 
at protein concentrations ≥ 4mg/ml. Model was generated using GASBOR program 
fitted by coordinates from published wild-type N-mtMCM protein crystal structure pdb 
file. Color balls stands for molecular surface of GASBOR model; color ribbons stand for 
N-terminal mtMCM monomers from crystal structure. a) Side view of “L” model; b) 
Side view rotated 90 degree along Y axis; c) Top view of  “L” model. 	  
 
This result is not consistent with the sizing column and light scattering 
results (monomer conformation) presented in Chapter II. The possible 
reason might be that for both sizing column and light scattering 
experiments, the protein concentrations were less than 2mg/ml. It is 
possible that when concentration of F172I mtMCM increases, the protein 
form bigger complex like dimers, hexamers or even larger complex. So at 
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high concentration, the F172I mtMCM might have multiple conformations 
in solution and possible equilibrium between all the conformations. This 
explains why the protein crystallization experiment, which requires high 
protein concentration and strict homogeneity of protein solution, did not 
succeed.  
The above results give us an idea of overall structure of the N-terminal 
F172I mutant with the absence of suitable crystals. It might not be very 
accurate, due to the heavy aggregation under high concentration, but do 
tell us lots of structural information and conformation possibilities, which 
will be helpful for further structural or biochemical study on mtMCM 
proteins. The SAXS experiment itself could be further improved with 
more data sets.  
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APPENDIXA 
ABSTRACTS FOR ADDITIONAL PUBLISHED WORK 
 
Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP 
subunits. Huayi Wang, Yan Yan, Qun Liu, Yanhua Huang, Yue Shen, Linjie Chen, 
Yi Chen, Qiuyue Yang, Quan Hao, KeWei Wang, and Jijie Chai. Nat Neurosci. 2007 
January; 10(1): 32–39. Published online 2006 December 24. doi: 10.1038/nn1822. 
 
Abstract: 
 
KChIPs coassemble with pore-forming Kv4 a subunits to form a native complex in the 
brain and heart and regulate the expression and gating properties of Kv4 K1 channels, 
but the mechanisms underlying these processes are unknown. Here we report a co-
crystal structure of the complex of human Kv4.3 N-terminus and KChIP1 at a 3.2-A˚ 
resolution. The structure reveals a unique clamping action of the complex, in which a 
single KChIP1 molecule, as a monomer, laterally clamps two neighboring Kv4.3 N-
termini in a 4:4 manner, forming an octamer. The proximal N-terminal peptide of 
Kv4.3 is sequestered by its binding to an elongated groove on the surface of KChIP1, 
which is indispensable for the modulation of Kv4.3 by KChIP1, and the same KChIP1 
molecule binds to an adjacent T1 domain to stabilize the tetrameric Kv4.3 channels. 
Taken together with biochemical and functional data, our findings provide a structural 
basis for the modulation of Kv4 by KChIPs.   
 
 
